Experimental nanomedicine delivers chemo drugs directly to tumors in mice
Researchers at the University of Chicago Medicine Comprehensive Cancer Center have developed a nanomedicine that increases the penetration and accumulation of chemotherapy drugs in tumor tissues and effectively kills cancer cells in mice. The researchers looked at a particular pathway known as stimulator of interferon genes (STING), whose activation increases the leakiness of blood vessels near the tumor.